Skip to main content
SpringerLink
Log in

Surgical Considerations in the Management of Primary Invasive Breast Cancer

  • Chapter
  • First Online:
Management of Breast Diseases

  • 1365 Accesses

Abstract

Patients with primary breast cancer might consider three surgical options: modified radical mastectomy (MT), MT with contralateral prophylactic mastectomy (CPM), and breast-conserving surgery (BCS). Following BCS, radiation therapy (RT) is often required to reduce the risk of ipsilateral breast tumor recurrence, although older patients with indolent tumors may not require radiotherapy after BCS. Moreover, radiotherapy is required for selected high-risk patients who undergo mastectomy. Relative contraindications to BCS include pregnancy, previous breast RT, active collagen vascular diseases, large tumor size in relation to breast size, multicentric disease, and mutation carriers (who are generally treated with bilateral mastectomy for unilateral breast cancer). Preoperative chemotherapy can be utilized to decrease the size of large tumors, allowing BCS to be feasible. Most women with primary breast cancer prefer the option of BCS with adjuvant RT. Paradoxically, there has been a trend in recent years toward the increased utilization of bilateral mastectomy (MT + CPM) for the treatment of unilateral breast cancer, despite a decreased risk for the development of contralateral breast cancer due to improved adjuvant systemic therapies. Sentinel lymph node biopsy (SLNB) is useful in determining the status of the regional lymph nodes while avoiding the morbidity associated with a more extensive axillary lymph node dissection (ALND). Multiple published randomized controlled studies have demonstrated the safety of omitting ALND in women with negative SLNB. Recently published randomized studies have provided evidence that SLNB alone is safe, even in instances where patients have a low burden of axillary disease in the sentinel nodes, particularly if these patients receive adjuvant radiotherapy and adjuvant systemic therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Virchow R. Cellular pathology. Philadelphia: JB Lippincott; 1863.

    Google Scholar 

  2. Halsted WS. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins hospital from June 1889 to January 1894. Ann Surg. 1894;20:55–497.

    Article  Google Scholar 

  3. Margoles RG. Surgical considerations for invasive breast cancer. Surg Clin North Am. 1999;79:1031–46.

    Article  Google Scholar 

  4. Bonnadonna G, Valagussa P. The contribution of medicine to the primary treatment of breast cancer. Cancer Res. 1988;48:2314–24.

    Google Scholar 

  5. Urban JA, Marjoni MA. Significance of internal mammary lymph node metastases in breast cancer. AJR Am J Roentgenol. 1971;111:130–6.

    Article  CAS  Google Scholar 

  6. Wagensteen OH. Another look at supraradical operation for breast cancer. Surgery. 1957;41:857–61.

    Google Scholar 

  7. Andreassen M, Dahl-Iversen E, Sorensen B. Extended exeresis of regional lymph nodes at operation for carcinoma of breast and the result of a 5-year follow-up of the first 98 cases with removal of the axillary as well as the supraclavicular glands. Acta Chir Scan. 1954;107:206–13.

    CAS  Google Scholar 

  8. Lacour J, Bucalossi P, Cacers E, et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Cancer. 1976;37:206–14.

    Article  CAS  PubMed  Google Scholar 

  9. McWhirter R. Simple mastectomy and radiotherapy in treatment of breast cancer. Br J Radiol. 1955;28:128–39.

    Article  CAS  PubMed  Google Scholar 

  10. Mustakalio S. Conservative treatment of breast carcinoma—review of 25-year follow-up. Clin Radiol. 1972;23:110–6.

    Article  Google Scholar 

  11. Margolese R. Surgical considerations in selecting local therapy. J Natl Cancer Inst Monogr. 1992;11:41–8.

    Google Scholar 

  12. Bloom HJG, Richardson WW, Harries EJ. Natural history of untreated breast cancer (1805–1933). BMJ. 1962;2:213–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Eng J Med. 1985;312:674–81.

    Article  CAS  Google Scholar 

  14. Cancer Research Campaign Working Party. Cancer research campaign (King’s/Cambridge) trial for early breast cancer. Lancet. 1980;2:55–60.

    Google Scholar 

  15. Veronesi U, Cascinelli N, Mariani L, et al. Twentyyear follow-up of a randomized study comparing breastconserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.

    Article  PubMed  Google Scholar 

  16. Arriagada R, Le MG, Rochard F, et al. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. J Clin Oncol. 1996;14:1558–64.

    Article  CAS  PubMed  Google Scholar 

  17. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.

    Article  PubMed  Google Scholar 

  18. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast-conservation therapy. Cancer. 2003;98:696–702.

    Article  Google Scholar 

  19. van Dongen JA, Voogd AC, Fentiman IS, et al. Longterm results of a randomized trial comparing breastconserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial. J Natl Cancer Inst. 2000;92:1143–50.

    Article  PubMed  Google Scholar 

  20. Bilchert-Toft M, Rose C, Anderson JA, et al. Danish randomized trial comparing breast-conservation therapy with mastectomy. J Natl Cancer Inst Monogr. 1992;11:19–25.

    Google Scholar 

  21. Lonning PE. Treatment of early breast cancer with conservation of the breast: a review. Acta Oncol. 1991;30:779–92.

    Article  CAS  PubMed  Google Scholar 

  22. Fowble B. Ipsilateral breast tumor recurrence following breast-conserving surgery for early stage invasive breast cancer. Acta Oncol. 1999;13(Suppl):9–17.

    Article  Google Scholar 

  23. Fisher B. Personal contributions to progress in breast cancer research and treatment. Semin Oncol. 1996;23:414–27.

    CAS  PubMed  Google Scholar 

  24. Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumor recurrence after lumpectomy. Lancet. 1991;338:327–31.

    Article  CAS  PubMed  Google Scholar 

  25. Kurtz JM, Spitalier JM, Amalric R, et al. The prognostic significance of late local recurrence after breastconserving therapy. Int J Radiat Oncol Biol Phys. 1990;18:87–93.

    Article  CAS  PubMed  Google Scholar 

  26. Donegan WL, Perez-Mesa CM, Watson FR. A biostatistical study of locally recurrent breast carcinoma. Surg Gynecol Obstet. 1966;122:529–40.

    CAS  PubMed  Google Scholar 

  27. Borger J, Kemperman H, Hart A, et al. Risk factors in breast-conservation therapy. J Clin Oncol. 1994;12:653–60.

    Article  CAS  PubMed  Google Scholar 

  28. Jatoi I, Proschan MA. Randomized trials of breastconserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results. Am J Clin Oncol. 2005;28(3):289–94.

    Article  PubMed  Google Scholar 

  29. Ving-Hung V, Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst. 2004;96:114–21.

    Google Scholar 

  30. Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005;366:2087–106.

    Article  Google Scholar 

  31. Turner BC, Harrold E, Matloff E, et al. BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations. J Clin Oncol. 1999;17:3017–24.

    Article  CAS  PubMed  Google Scholar 

  32. Kinzler KW, Vogelstein B. Gatekeepers and caretakers. Nature. 1997;386:761–3.

    Article  CAS  PubMed  Google Scholar 

  33. Pierce LJ, Strawderman M, Narod SA, et al. Effect of radiotherapy after breast-conservig treatment in women with breast cancer and germline BRCA ½ mutations. J Clin Oncol. 2000;18(19):3360–9.

    Article  CAS  PubMed  Google Scholar 

  34. Metcalfe KA, Lubinski J, Ghadirian P, et al. Prediction of contralateral prophylactic mastectomy in women with a BRCA 1 or BRCA 2 mutation: the hereditary breast cancer clinical study group. J Clin Oncol. 2008;26(7):1093–7.

    Article  PubMed  Google Scholar 

  35. Benson J, Jatoi I. Management options breast cancer: case histories, best practice, and clinical decision-making. London: Informa Healthcare; 2009.

    Book  Google Scholar 

  36. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351(10):971–7.

    Article  CAS  PubMed  Google Scholar 

  37. Atkins H, Hayward JL, Klugman OJ, et al. Treatment of early breast cancer: a report after ten years of a clinical trial. BMJ. 1972;2(5811):423–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Winchester O, Cox J. Standards for breast-conservation treatment. CA Cancer J Clin. 1992;42:134–62.

    Article  CAS  PubMed  Google Scholar 

  39. Foster RS, Wood WC. Alternative strategies in the management of primary breast cancer. Arch Surg. 1998;133:1182–6.

    Article  PubMed  Google Scholar 

  40. Veronesi D, Bonadonna G, Zurrida S, et al. Conservation surgery after primary chemotherapy in large carcinomas of the breast. Ann Surg. 1995;222:609–11.

    Article  Google Scholar 

  41. Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295–303.

    Article  CAS  PubMed  Google Scholar 

  42. Solin LJ, Orel SG, Hwang SG, et al. Relationship of breast magnetic resonance imaging to outcome after breastconservation treatment with radiation for women with early stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol. 2008;26:386–91.

    Article  PubMed  Google Scholar 

  43. Nattinger AB, Hoffmann RG, Kneusel RT, et al. Relation between appropriateness of primary therapy for early stage breast carcinoma and increased use of breast conserving surgery. Lancet. 2000;356:1148–53.

    Article  CAS  PubMed  Google Scholar 

  44. Nattinger AB, Gottlieb MS, Veum J, et al. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med. 1992;326:1147–9.

    Article  Google Scholar 

  45. Kelemen JJ, Poulton T, Swartz MT, et al. Surgical treatment of early stage breast cancer in the department of defense healthcare system. J Am Coll Surg. 2001;192:293–7.

    Article  PubMed  Google Scholar 

  46. Freedman RA, He Y, Winer EP, Keating NL. Trends in racial and age disparities in definitive local therapy of early stage breast cancer. J Clin Oncol. 2009;27(5):713–9.

    Article  PubMed  Google Scholar 

  47. Tuttle TM, Haberman EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25(33):5203–309.

    Article  PubMed  Google Scholar 

  48. Nattinger AB, Hoffmann RG, Shapiro R, et al. The effect of legislative requirements on the use of breastconserving surgery. N Engl J Med. 1996;335:1035–40.

    Article  CAS  PubMed  Google Scholar 

  49. Dolan J, Granchi TS, Miller CC, et al. Low use of breast-conservation surgery in medically indigent populations. Am J Surg. 1999;178:470–4.

    Article  CAS  PubMed  Google Scholar 

  50. Collins ED, Moore CP, Clay KF, et al. Can women with early stage breast cancer make an informed decision for mastectomy? J Clin Oncol. 2009;27(4):519–25.

    Article  PubMed  Google Scholar 

  51. Jatoi I, Benson JR, Liau SS, Chen Y, Cisco RM, Norton JA, et al. The role of surgery in cancer prevention. Curr Probl Surg. 2010;47(10):750–830.

    Article  PubMed  Google Scholar 

  52. Jatoi I, Benson JR. The case against routine preoperative breast MRI. Future Oncol. 2013;9(3):347–53.

    Article  CAS  PubMed  Google Scholar 

  53. Sorbero ME, Dick AW, Beckjord EB, Ahrendt G. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol. 2009;16(6):1597–605.

    Article  PubMed  Google Scholar 

  54. Murphy JA, Milner TD, O’Donoghue JM. Contralateral risk-reducing mastectomy in sporadic breast cancer. Lancet Oncol. 2013;14(7):e262–9.

    Article  PubMed  Google Scholar 

  55. Institute nc. surveillance epidemiology and end results program (2014) Available from: http://seer.cancer.gov.

  56. Jatoi I, Parsons HM. Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias. Breast Cancer Res Treat. 2014;148(2):389–96.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Dowden RV, Rosato FE, McGraw JB. Reconstruction of the breast after mastectomy for cancer. Surg Gynecol Obstet. 1979;149:109–15.

    CAS  PubMed  Google Scholar 

  58. Johnson CH, van Heerden JA, Donohue JH, et al. Oncological aspects of immediate breast reconstruction following mastectomy for malignancy. Arch Surg. 1989;124:819–23.

    Article  CAS  PubMed  Google Scholar 

  59. Vinton AL, Traverso W, Zehring RD. Immediate breast reconstruction following mastectomy is as safe as mastectomy alone. Arch Surg. 1990;125:1303–8.

    Article  CAS  PubMed  Google Scholar 

  60. Dean C, Chetty D, Forrest APM. Effects of immediate breast reconstruction on psychosocial morbidity after mastectomy. Lancet. 1983;1:459–62.

    Article  CAS  PubMed  Google Scholar 

  61. Damen TH, Mureau MA, Timman R, et al. The pleasing end result after DIEP flap breast reconstruction: a review of additional operations. J Plast Reconstr Aesthet Surg. 2009;62(1):71–6.

    Article  CAS  PubMed  Google Scholar 

  62. Jatoi I, Kaufmann M, Petit JY. Atlas of breast surgery. Heidelberg: Springer; 2006.

    Google Scholar 

  63. Corral CJ, Mustoe TA. Special problems in breast cancer therapy: controversy in breast reconstruction. Surg Clin North Am. 1996;76:309–26.

    Article  CAS  PubMed  Google Scholar 

  64. Hulka BS, Kerkvliet NL, Tugwell P. Experience of a scientific panel formed to advise the federal judiciary on silicone breast implants. N Engl J Med. 2000;342:812–5.

    Article  CAS  PubMed  Google Scholar 

  65. Nyren O, Yin L, Josefsson S, et al. Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ. 1998;316:417–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Janowsky EC, Kupper LL, Hulka BS. Meta-analyses of the relation between silicone breast implants and the risk of connective tissue diseases. N Engl J Med. 2000;342:781–90.

    Article  CAS  PubMed  Google Scholar 

  67. Schneider WJ, Hill HL Jr, Brown RG. Latissimus dorsi myocutaneous flap for breast reconstruction. Br J Plast Surg. 1977;30:277–81.

    Article  CAS  PubMed  Google Scholar 

  68. Amez Z, Smith R, Eder R. Breast reconstruction by the free lower transverse rectus abdominis muscular cutaneous flap. Br J Plast Surg. 1988;41:500–7.

    Article  Google Scholar 

  69. Alderman AK, McMahon L, Wilkins EG. The national utilization of immediate and early delayed breast reconstruction and the impact of sociodemographic factors. Plast Reconstr Surg. 2003;111:695–703.

    Article  PubMed  Google Scholar 

  70. Alderman AK, Wei Y, Birkmeyer JD. Use of breast reconstruction after mastectomy following the Women’s Health and Cancer Rights Act. JAMA. 2006;295(4):387–8.

    CAS  PubMed  Google Scholar 

  71. Jatoi I. Management of the axilla in primary breast cancer. Surg Clin North Am. 1999;79:1061–73.

    Article  CAS  PubMed  Google Scholar 

  72. Veronesi U, Rilke R, Luini A, et al. Distribution of axillary node metastases by level of invasion. Cancer. 1987;59:682–7.

    Article  CAS  PubMed  Google Scholar 

  73. Morrow M. Axillary dissection: when and how radical? Semin Surg Oncol. 1996;12:321–7.

    Article  CAS  PubMed  Google Scholar 

  74. Harris JR, Osteen RT. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat. 1985;5:17–21.

    Article  CAS  PubMed  Google Scholar 

  75. Samphao S, Eremin JM, El-Sheemy M, Eremin O. Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach. Ann Surg Oncol. 2009;15(5):1282–96.

    Article  Google Scholar 

  76. Epstein RI. Routine or delayed axillary dissection for primary breast cancer? Eur J Cancer. 1995;31A:1570–3.

    Article  CAS  PubMed  Google Scholar 

  77. Sacks NPM, Baum M. Primary management of carcinoma of the breast. Lancet. 1993;342:1402–8.

    Article  CAS  PubMed  Google Scholar 

  78. Baxter N, McCready DR, Chapman JA, et al. Clinical behavior of untreated axillary nodes after local treatment for primary breast cancer. Ann Surg Oncol. 1996;3:235–40.

    Article  CAS  PubMed  Google Scholar 

  79. Graverson HP, Bilchert-Toft M, Andersen J, et al. Danish breast cancer cooperative group. Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla. Eur J Surg Oncol. 1988;14:407–12.

    Google Scholar 

  80. Jatoi I, Hilsenbeck SG, Clark GM, et al. The significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol. 1999;17:2334–40.

    Article  CAS  PubMed  Google Scholar 

  81. Jatoi I, Anderson WF, Rosenberg PS. Qualitative age interactions in breast cancer: a tale of two diseases? Am J Clin Oncol. 2008;31:504–6.

    Article  PubMed  Google Scholar 

  82. Cabanes PA, Salmon RI, Vilcoq JP, et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet. 1992;339:1245–8.

    Article  CAS  PubMed  Google Scholar 

  83. Gelber RD, Goldhirsch A, Coates AS. Adjuvant therapy for breast cancer: understanding the overview. J Clin Oncol. 1993;11:580–5.

    Article  CAS  PubMed  Google Scholar 

  84. Lonning PE. Breast cancer prognostication and prediction: are we making progress? Ann Oncol. 2007;18(Suppl 8):viii 3–7.

    Google Scholar 

  85. Bold RI, Mansfield PF, Berger DH, et al. Prospective, randomized, double-blind study of prophylactic antibiotics in axillary lymph node dissection. Am J Surg. 1998;176:239–43.

    Article  CAS  PubMed  Google Scholar 

  86. Coit DG, Peters M, Brennan MF. A prospective randomized trial of perioperative cefazolin treatment in axillary and groin dissection. Arch Surg. 1991;126:1366–72.

    Article  CAS  PubMed  Google Scholar 

  87. Rotstein C, Ferguson R, Cummings KM, et al. Determinants of clean surgical wound infections for breast procedures at an oncology center. Infect Control Hosp Epidemiol. 1992;13:207–14.

    Article  CAS  PubMed  Google Scholar 

  88. Ivens D, Hoe AL, Podd TJ, et al. Assessment of morbidity from complete axillary dissection. Br J Cancer. 1992;66:136–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Lyman GH, Giuliano AE, Somerfield MR, et al. American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early stage breast cancer. J Clin Oncol. 2005;23:7703–20.

    Article  PubMed  Google Scholar 

  90. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456–66.

    Article  CAS  PubMed  Google Scholar 

  91. Morton DL, Wen DR, Wong JR, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–9.

    Article  CAS  PubMed  Google Scholar 

  92. Chen AY, Halpern MT, Schrag MM, et al. Disparities and trends in sentinel lymph node biopsy among early stage breast cancer patients (1998–2005). J Natl Cancer Inst. 2008;100(7):462–74.

    Article  PubMed  Google Scholar 

  93. Giuliano AE, Jones RC, Brennan M. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997;15:2345–50.

    Article  CAS  PubMed  Google Scholar 

  94. Veronesi D, Paganelli G, Galimberti V. Sentinel node biopsy to avoid dissection in breast cancer with clinically negative lymph nodes. Lancet. 1997;349:1864–7.

    Article  CAS  PubMed  Google Scholar 

  95. Smith LF, Cross MJ, Klimberg VS. Subareolar injection is a better technique for sentinel node biopsy. Am J Surg. 2000;180:434–7.

    Article  CAS  PubMed  Google Scholar 

  96. Morrow M, Rademaker AW, Bethke KP, et al. Learning sentinel node biopsy: results of a prospective trial of two techniques. Surgery. 1999;126:714–20.

    Article  CAS  PubMed  Google Scholar 

  97. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel node lymphadectomy. Ann Surg. 1995;222:394–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. McMasters KM, Giuliano AE, Ross MI, et al. Sentinel lymph node biopsy for breast cancer—not yet standard of care. N Engl J Med. 1998;339:990–5.

    Article  CAS  PubMed  Google Scholar 

  99. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349(6):546–53.

    Article  PubMed  Google Scholar 

  100. Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology group trial Z0011. J Clin Oncol. 2007;25:3657–63.

    Article  PubMed  Google Scholar 

  101. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst. 2006;98(9):599–609.

    Article  PubMed  Google Scholar 

  102. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996;276:1818–22.

    Google Scholar 

  103. Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252:426–32.

    PubMed  Google Scholar 

  104. American Joint Committee on Cancer Breast Cancer Staging 7th edition. Available from: https://cancerstaging.org/. Accessed 28 May 2016.

  105. Galimberti VV. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14:297.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Solá MM. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000. Ann Surg Oncol. 2013;20:120.

    Article  PubMed  Google Scholar 

  107. Goyal AA, Dodwell D. POSNOC: a randomised trial looking at axillary treatment in women with one or two sentinel nodes with macrometastases. J Clin Oncol (Royal College of Radiologists (Great Britain)). 2015;27:692.

    Google Scholar 

  108. Donker MM. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15:1303.

    Article  PubMed  PubMed Central  Google Scholar 

  109. Kuehn TT. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14:609.

    Article  PubMed  Google Scholar 

  110. Boughey JCJ. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310:1455.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  111. Boileau JJ. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33:258.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX, 7738, USA

    Carissia Calvo

  2. Division of Surgical Oncology and Endocrine Surgery, University of Texas Health Science Center, 7703 Floyd Curl Drive, Mail Code 7738, San Antonio, TX, 78229, USA

    Ismail Jatoi

Authors
  1. Carissia Calvo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ismail Jatoi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ismail Jatoi .

Editor information

Editors and Affiliations

  1. Department of Surgery, University of Texas Health Science Center, San Antonio, Texas, USA

    Ismail Jatoi

  2. Obstetrics and Gynecology, University Medical Center Schleswig-Holstein, Luebeck, Germany

    Achim Rody

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Calvo, C., Jatoi, I. (2016). Surgical Considerations in the Management of Primary Invasive Breast Cancer. In: Jatoi, I., Rody, A. (eds) Management of Breast Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-46356-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-46356-8_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-46354-4

  • Online ISBN: 978-3-319-46356-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation